IgA-Antigliadin antibodies in IgA mesangial nephropathy (Berger's disease) A FORNASIERI, R A SINICO, P MALDIFASSI, P BERNASCONI, M VEGNI, G D'AMICO Abstract Circulating IgA-antigliadin antibodies were detected with enzyme linked immunosorbent assay (ELISA) in four of 121 patients (3%) who had IgA mesangial nephropathy and 14 of 17 children (82%) who had untreated coeliac disease. No positive cases were present in the 54 healthy subjects ofthe control group. Three patients who had IgA nephropathy and IgA-antigliadin antibodies underwent jejunal biopsy, and two showed mucosal atrophy. In these two patients urinary abnormalities, together with the IgA-antigliadin antibodies, disappeared completely after three months and five months, respectively, of following a gluten free diet. Circulating IgA immune complexes were found in most patients who had coeliac disease and Berger's disease associated with IgA-antigliadin antibodies, suggesting overactivity of the B cells producing IgA in both conditions. By contrast, a circulating IgA rheumatoid factor was detectable in three ofthe four patients who had IgA nephropathy and asymptomatic coeliac disease but was always absent in children who had coeliac disease but did not show signs of renal disease.
These 
Coeliac disease
IgA-antigliadin antibodies measured in serum from patients who had IgA nephropathy, from normal controls, and from patients who had coeliac disease. Normal value < 12 arbitrary units.
After three washes with phosphate buffered saline containing 0-05% Tween 20 the plates were blocked by incubating them in phosphate bufferd saline supplemented with 10 mg human serum albumin/ml for two hours at room temperature. After three more washes the plates were then incubated with serum diluted in phosphate buffered saline-Tween for three hours at room temperature. After washing again 50 t1 goat antihuman a chain antiserum conjugated with horseradish peroxidase (Cappel) diluted 1/1000 in phosphate buffered saline-Tween was added. After the plates had been incubated for one hour at 370C and washed 50 td substrate was added. The absorbance was read at 405 nm with a Titertek Multiskan.
The titre of circulating IgA IC was determined with an ELISA modification of the anti-C3 solid phase assay. 12 IgA rheumatoid factor was measured by ELISA as described,6 with plates coated with human IgG and goat F(ab)2 antihuman IgA conjugated with peroxidase.
The results were expressed in arbitrary units for IgA-antigliadin antibody 79
IgA-antigliadin antibodies and IgA nephropathy (table) . These immunological abnormalities disappeared in the two patients who followed a gluten free diet. Our results show that IgA-antigliadin antibodies do not play a large part in the development of Berger's disease. Our study also shows, however, that a small population of patients, assumed to have a primary IgA mesangial nephropathy, are in fact affected by gluten enteropathy despite a complete absence of clinical symptoms of coeliac disease. Such a finding has important therapeutical implications, as in the two patients who had circulating IgAantigliadin antibodies and mucosal atrophy as shown by biopsy a gluten free diet followed for a few months resulted in the complete disappearance of the urinary abnormalities and a considerable reduction in the mesangial deposits of IgA. We therefore think that IgA-antigliadin antibodies should be looked for in all cases of "primary" IgA mesangial nephropathy so that the minority of patients in whom the renal disease is associated with a clinically unsuspected coeliac disease can be detected.
The mechanism of this association is unclear. As the incidence of IgA mesangial nephropathy is low in patients who have overt coeliac disease we think that the abnormality of the mucosal immune response that seems to characterise Berger's disease (increased activity of immunocompetent cells committed to producing IgA antibodies"3 14) must be present together with the jejunal lesions typical of coeliac disease for the renal disease to be manifest. This hypothesis is supported by the presence of IgA rheumatoid factor only in patients who have coeliac disease and IgA nephropathy and not in coeliac patients who do not have nephropathy.
The coexistence of these two specific disorders may explain why the proportion of patients in our population who had gliadin dependent mucosal lesions was definitely higher than that recently described by Hed et al in a large population of healthy blood donors screened for the presence of IgA-antigliadin antibodies.'5 Both studies show that subclinical forms of coeliac disease are probably more common than was believed in the past and that in predisposed patients the renal disease may be its only clinical manifestation.
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Introduction
There is concern about the potential consequences of increasing alcohol consumption in women. I 2 It has been suggested that women may develop liver damage at low levels of daily alcohol consumption.34 Few data are available, however, from which to determine the level of alcohol consumption at which an important increase in the risk of alcohol related cirrhosis occurs. Furthermore, we do not know whether other factors such as hepatotoxic drug use or a history of other liver disease interact with alcohol to increase the risk of cirrhosis.' 6 We report the results of a case-control study which was designed to determine in women the relative risks of cirrhosis with a likely primary alcohol aetiology at various levels ofdaily alcohol consumption. The role,of several factors hypothesised to interact with alcohol in the development ofalcohol related cirrhosis was also investigated.
Subjects and methods
Over 20 months (July 1982 to February 1984) all women with a first diagnosis of cirrhosis of the liver admitted to eight main hospitals in the Sydney metropolitan region were identified prospectively. Women were eligible for selection as cases if they resided in the Sydney metropolitan area, were not lifetime abstainers from alcohol, and did not have cirrhosis with a primary aetiology known not to be related to alcohol. Fifty two women met these criteria. Of these, seven were considered too ill to be interviewed and 41 (91%) ofthe remainder consented to participate. In 37 of these women the hospital diagnosis indicated cirrhosis of probable primary alcohol aetiology. We judged 31 women to have "definite" cirrhosis on the basis of a liver biopsy (in 10), an isotope liver scan (in 16), or, when liver biopsy was contraindicated, standard clinical signs and biochemical tests7 (in five). In six women there was evidence of "possible" cirrhosis; in these cases liver biopsy was not contraindicated and diagnoses were based on clinical signs and biochemical tests alone. The remaining four women had hospital diagnoses of cryptogenic cirrhosis. In two of these women diagnoses were
